| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
|
Schild, Steven E.
|
|
|
23 |
5 |
p. e317-e320
|
artikel
|
| 2 |
A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer
|
Handa, Yoshinori
|
|
|
23 |
5 |
p. 393-401
|
artikel
|
| 3 |
Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC
|
Behel, Vichitra
|
|
|
23 |
5 |
p. 410-418
|
artikel
|
| 4 |
CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy
|
Mikami, Naoto
|
|
|
23 |
5 |
p. 428-437
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
23 |
5 |
p. A11
|
artikel
|
| 6 |
Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor
|
Shinno, Yuki
|
|
|
23 |
5 |
p. 386-392
|
artikel
|
| 7 |
Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy
|
Joshi, Ishani
|
|
|
23 |
5 |
p. 438-445
|
artikel
|
| 8 |
Impact of Comorbidities on Lung Cancer Screening Evaluation
|
Robinson, Eric M.
|
|
|
23 |
5 |
p. 402-409
|
artikel
|
| 9 |
Management of Bronchial Adenoma/Ciliated Muconodular Papillary Tumor with Definitive Stereotactic Body Radiation Therapy (SBRT): A Case Report
|
Maroongroge, Sean
|
|
|
23 |
5 |
p. e335-e338
|
artikel
|
| 10 |
Prevalence And Impact of Medical Comorbidities in A Real‐World Lung Cancer Screening Population
|
Majeed, Harris
|
|
|
23 |
5 |
p. 419-427
|
artikel
|
| 11 |
Pulmonary Ewing Sarcoma Mimicking Small Cell Lung Cancer
|
Abdelghany, Khaled
|
|
|
23 |
5 |
p. e330-e334
|
artikel
|
| 12 |
Quantifying The Medical Impact of A Missed Diagnosis of Non-Small Cell Lung Cancer on Chest Imaging
|
Camidge, D. Ross
|
|
|
23 |
5 |
p. 377-385
|
artikel
|
| 13 |
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer
|
Rimner, Andreas
|
|
|
23 |
5 |
p. e325-e329
|
artikel
|
| 14 |
Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival
|
Nagata, Shunichi
|
|
|
23 |
5 |
p. e321-e324
|
artikel
|
| 15 |
Systemic Treatment Patterns and Outcomes in Patients With EGFR Mutated Non-small Cell Lung Cancer and Leptomeningeal Disease
|
Merkhofer, Cristina M.
|
|
|
23 |
5 |
p. 446-455
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
23 |
5 |
p. A13-A15
|
artikel
|
Tijdschrift beschrijving